Table 1

Mean (± S.D.) pharmacokinetic parameters of 2-AP after 1-min i.v. infusion of the drug, 10, 20, 50, and 100 mg/kg body weight, to rats

ParametersBody Weight
10 mg/kg (N= 8)20 mg/kg (N = 9)50 mg/kg (N = 9)100 mg/kg (N = 6)
Terminal half-life (min)(211  ± 51.1)1-a (192  ± 27.2)540  ± 116569  ± 105
AUC (μg min/ml)222  ± 45.2409  ± 68.61100  ± 1712190  ± 345
MRT (min)(50.4  ± 8.80)(63.8  ± 16.2)102  ± 17.0129  ± 5.20
CL(ml/min/kg body weight)46.0  ± 9.5748.9  ± 9.1745.6  ± 7.0145.7  ± 7.28
V SS (ml/kg body weight)(2320  ± 869)(2880  ± 1360)4580  ± 6205890  ± 1010
Ae 0–24 h (% of dose)0.0673  ± 0.05160.526  ± 0.3590.345  ± 0.07900.0926  ± 0.0544
  • 1-a The numbers in parentheses represent pharmacokinetic parameters of 2-AP at the doses of 10 and 20 mg/kg body weight. Because the detection of plasma concentrations of 2-AP at 10 and 20 mg/kg body weight was shorter than those at 50 and 100 mg/kg body weight, these data were not included in statistical analysis.